V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20160194 | 20061679 | 1.56 | 74.3 | Palliative (P) | 2016-10-11 | 2016-11-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100610646 |
| 20160196 | 20061680 | 1.7 | 68.9 | Neo-adjuvant (N) | 2017-12-19 | 2018-01-07 | ECX | N | N | ECX | 100674535 |
| 20160198 | 20061681 | 1.74 | 68.7 | Neo-adjuvant (N) | 2018-12-29 | 2018-12-30 | ECX | 02 | N | ECX | 101688008 |
| 20160199 | 20061682 | null | 85.8 | Palliative (P) | 2018-01-23 | 2018-01-23 | ECX | N | N | ECX | 101783078 |
| 20160201 | 20061683 | 1.8 | 88 | Palliative (P) | 2016-03-21 | 2016-04-11 | ECX | N | N | ECX | 100670053 |
| 20160202 | 20061684 | 1.67 | 74.1 | Adjuvant (A) | 2018-10-08 | 2018-10-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100078633 |
| 20160203 | 20061685 | 1.53 | 59 | null | 2016-09-20 | 2016-10-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100370859 |
| 20160204 | 20061686 | 1.78 | 93.5 | Curative (C) | 2019-03-27 | 2019-04-20 | CAPECITABINE + GEMCITABINE | N | null | CAPECITABINE + GEMCITABINE | 100534066 |
| 20160208 | 20061687 | 1.6 | 59.2 | Neo-adjuvant (N) | 2018-11-16 | 2018-11-16 | ECX | 02 | N | ECX | 101174275 |
| 20160210 | 20061688 | null | null | Neo-adjuvant (N) | 2018-03-03 | 2018-03-04 | Gemcitabine + Capecitabine | N | N | ECX | 100016080 |
| 20160211 | 20061689 | 1.47 | 81.5 | Neo-adjuvant (N) | 2018-12-18 | 2018-12-25 | ECX | 02 | N | ECX | 100556147 |
| 20160212 | 20061690 | 1.5 | 93.7 | Adjuvant (A) | 2018-03-09 | 2018-03-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100416827 |
| 20160213 | 20061691 | 1.76 | 78.75 | Palliative (P) | 2019-07-17 | 2019-07-25 | ECX | N | N | ECX | 100009776 |
| 20160214 | 20061692 | 1.7 | 58.6 | Palliative (P) | 2018-07-14 | 2018-08-08 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101072540 |
| 20160216 | 20061693 | 1.78 | 76 | Adjuvant (A) | 2016-04-14 | 2016-04-21 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101394626 |
| 20160217 | 20061694 | 1.62 | 80 | Palliative (P) | 2019-07-02 | 2019-07-03 | ECX | N | null | ECX | 100725322 |
| 20160220 | 20061695 | 1.75 | 62.3 | Curative (C) | 2018-03-22 | 2018-03-31 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101327646 |
| 20160221 | 20061696 | 1.55 | 62 | Palliative (P) | 2018-01-01 | 2018-01-12 | ECX | 2 | N | ECX | 101268497 |
| 20160222 | 20061697 | 1.68 | 65.9 | Neo-adjuvant (N) | 2018-08-26 | 2018-09-11 | ECX | N | N | ECX | 100845748 |
| 20160224 | 20061698 | 1.65 | 71.8 | Palliative (P) | 2018-04-21 | 2018-05-12 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100005835 |
| 20160225 | 20061699 | 1.6 | 92.3 | Adjuvant (A) | 2017-08-14 | 2017-08-19 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100414217 |
| 20160227 | 20061700 | 1.51 | 46.6 | Palliative (P) | 2019-07-22 | 2019-07-28 | ECX | N | N | ECX | 101859877 |
| 20160228 | 20061701 | 1.65 | 94.5 | Palliative (P) | 2016-09-29 | 2016-10-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100922235 |
| 20160229 | 20061702 | 1.8 | 78 | Adjuvant (A) | 2018-11-30 | 2018-12-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101195338 |
| 20160231 | 20061703 | 1.72 | 82.2 | Adjuvant (A) | 2018-02-10 | 2018-03-03 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101625489 |
| 20160234 | 20061704 | 1.59 | 63.2 | Adjuvant (A) | 2018-06-11 | 2018-07-02 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101778115 |
| 20160238 | 20061705 | 1.68 | 75.3 | Neo-adjuvant (N) | 2017-02-18 | 2017-02-25 | ECX | 02 | null | ECX | 101021319 |
| 20160239 | 20061706 | 1.72 | 65.4 | Palliative (P) | 2019-06-05 | 2019-06-08 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100828358 |
| 20160240 | 20061707 | 1.83 | 91 | Neo-adjuvant (N) | 2016-07-27 | 2016-08-23 | ECX | N | N | ECX | 100776395 |
| 20160243 | 20061708 | 1.77 | 64.3 | Curative (C) | 2017-05-27 | 2017-07-03 | ECX | N | null | ECX | 100800923 |
| 20160246 | 20061709 | 1.68 | 53.3 | Adjuvant (A) | 2017-06-15 | 2017-07-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101063921 |
| 20160247 | 20061710 | 1.93 | 65.7 | null | 2019-05-16 | 2019-06-06 | Gemcitabine + Capecitabine | N | N | ECX | 101187671 |
| 20160248 | 20061711 | 1.51 | 84.7 | null | 2018-08-02 | 2018-08-17 | ECX | N | null | CAPECITABINE + GEMCITABINE | 100961602 |
| 20160249 | 20061712 | 1.65 | 61.2 | Adjuvant (A) | 2016-08-23 | 2016-09-09 | CAPECITABINE + GEMCITABINE | 02 | Y | CAPECITABINE + GEMCITABINE | 100491494 |
| 20160250 | 20061713 | 1.71 | 43.4 | Adjuvant (A) | 2019-01-25 | 2019-02-16 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100774519 |
| 20160251 | 20061714 | 1.78 | 58.6 | Adjuvant (A) | 2016-08-08 | 2016-08-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100094307 |
| 20160252 | 20061715 | 1.49 | 84.6 | Curative (C) | 2018-05-04 | 2018-05-17 | ECX | N | N | ECX | 101270184 |
| 20160253 | 20061716 | null | 69.6 | Neo-adjuvant (N) | 2017-07-24 | 2017-07-28 | ECX | 02 | null | ECX | 101282981 |
| 20160254 | 20061717 | 1.54 | null | Neo-adjuvant (N) | 2017-04-25 | 2017-04-25 | ECX | 02 | N | ECX | 100843589 |
| 20160257 | 20061718 | 1.62 | 48 | Curative (C) | 2018-01-18 | 2018-02-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101294598 |
| 20160258 | 20061719 | null | 64 | Neo-adjuvant (N) | 2018-11-19 | 2018-12-06 | ECX | N | null | ECX | 101224716 |
| 20160259 | 20061720 | 1.63 | 49.4 | Palliative (P) | 2019-08-27 | 2019-08-27 | ECX | 02 | N | ECX | 101451648 |
| 20160260 | 20061721 | 1.78 | 103 | Adjuvant (A) | 2019-02-12 | 2019-02-24 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 100244459 |
| 20160261 | 20061722 | 1.74 | 117 | Neo-adjuvant (N) | 2017-06-15 | 2017-06-16 | ECX | 02 | N | ECX | 101810258 |
| 20160262 | 20061723 | 1.63 | 126.9 | Palliative (P) | 2017-01-16 | 2017-01-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101486122 |
| 20160263 | 20061724 | 1.71 | 63.7 | null | 2019-01-22 | 2019-01-31 | ECX | N | N | ECX | 100718491 |
| 20160265 | 20061725 | 1.63 | 58 | Neo-adjuvant (N) | 2016-07-11 | 2016-07-18 | ECX | 02 | N | ECX | 101308910 |
| 20160267 | 20061726 | 1.55 | 105.6 | Curative (C) | 2019-08-04 | 2019-08-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101085153 |
| 20160268 | 20061727 | 1.7 | 67.2 | Palliative (P) | 2018-04-01 | 2018-04-22 | ECX | N | N | ECX | 100015247 |
| 20160270 | 20061728 | 1.7 | 54.8 | Neo-adjuvant (N) | 2019-06-12 | 2019-06-25 | ECX | 02 | N | ECX | 101702576 |